794 related articles for article (PubMed ID: 7533185)
1. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
2. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology.
Massey WA; Guo CB; Dvorak AM; Hubbard WC; Bhagavan BS; Cohan VL; Warner JA; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1991 Sep; 147(5):1621-7. PubMed ID: 1715365
[TBL] [Abstract][Full Text] [Related]
3. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.
de Paulis A; Marinò I; Ciccarelli A; de Crescenzo G; Concardi M; Verga L; Arbustini E; Marone G
Arthritis Rheum; 1996 Jul; 39(7):1222-33. PubMed ID: 8670335
[TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
6. The human heart as a shock organ in anaphylaxis.
Marone G; Bova M; Detoraki A; Onorati AM; Rossi FW; Spadaro G
Novartis Found Symp; 2004; 257():133-49; discussion 149-60, 276-85. PubMed ID: 15025396
[TBL] [Abstract][Full Text] [Related]
7. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
8. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
9. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
[TBL] [Abstract][Full Text] [Related]
10. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
11. Human heart mast cells: a definitive case of mast cell heterogeneity.
Patella V; de Crescenzo G; Ciccarelli A; Marinò I; Adt M; Marone G
Int Arch Allergy Immunol; 1995 Apr; 106(4):386-93. PubMed ID: 7536502
[TBL] [Abstract][Full Text] [Related]
12. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V; Casolaro V; Björck L; Marone G
J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
[TBL] [Abstract][Full Text] [Related]
13. Human skin mast cells: their dispersion, purification, and secretory characterization.
Benyon RC; Lowman MA; Church MK
J Immunol; 1987 Feb; 138(3):861-7. PubMed ID: 2433332
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of histamine release from cultured human mast cells.
Igarashi Y; Kurosawa M; Ishikawa O; Miyachi Y; Saito H; Ebisawa M; Iikura Y; Yanagida M; Uzumaki H; Nakahata T
Clin Exp Allergy; 1996 May; 26(5):597-602. PubMed ID: 8735874
[TBL] [Abstract][Full Text] [Related]
15. The role of basophils in allergic disease.
Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional characterization of mast cells derived from renal tumor tissues.
Beil WJ; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl HC; Lechner K; Valent P
Exp Hematol; 1998 Feb; 26(2):158-69. PubMed ID: 9472805
[TBL] [Abstract][Full Text] [Related]
17. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release.
Yamaguchi M; Sayama K; Yano K; Lantz CS; Noben-Trauth N; Ra C; Costa JJ; Galli SJ
J Immunol; 1999 May; 162(9):5455-65. PubMed ID: 10228025
[TBL] [Abstract][Full Text] [Related]
18. Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production.
Kitahata Y; Nunomura S; Terui T; Ra C
Int Arch Allergy Immunol; 2010; 152 Suppl 1():22-31. PubMed ID: 20523060
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction.
Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB
J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649
[TBL] [Abstract][Full Text] [Related]
20. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
